How much does Mounjaro cost? With and without insurance

What Mounjaro costs per month

List price is about $1,080 a month — and it’s the number almost nobody actually pays. What you pay depends less on the pharmacy than on one question: was it prescribed for type 2 diabetes, or for weight loss? Same pen, wildly different bills. Figures below are drafts pending verification.

Mounjaro cost without insurance

How much is Mounjaro without insurance? About $1,080 a month at list price — call it $13,000 a year. Pharmacy cash prices float around that figure, sometimes a little above it once dispensing markups land.

Three things worth knowing before you pay cash:

• Every strength costs the same. The 2.5 mg starter pen and the 15 mg maximum list at the same price (⚠ verify), so moving up the dose ladder doesn’t raise your bill — and stretching doses to save money mostly just undermines the schedule.
• The savings card won’t rescue you. Its headline price requires commercial insurance that already covers Mounjaro — without coverage, the card does little to nothing (⚠ verify current terms).
• There’s no cash-pay program. Lilly sells discounted self-pay vials for Zepbound through its direct channel, but not for Mounjaro (⚠ verify) — one more way the system nudges self-paying weight-loss patients toward the other label.

If you’re staring at that number, the honest next step usually isn’t a coupon hunt — it’s the coverage question below.

Does insurance cover Mounjaro?

For type 2 diabetes: usually yes. Mounjaro is one of the better-covered GLP-1s — most commercial formularies include it, prior authorization is typically a formality when a T2D diagnosis is on file, and copays land anywhere from $25 (with the savings card) to a few hundred dollars a month.

For weight loss: usually no. The prior authorization asks one question — does this patient have type 2 diabetes? — and an off-label weight prescription can’t answer it. The denial isn’t a paperwork error to fix with resubmission; it’s the system working as designed.

The fix, most of the time, is Zepbound. Same molecule, same doses, same maker — but it carries the weight-management label, so weight-loss prior authorizations can actually clear. If your plan covers weight-loss medication at all, Zepbound is the version it covers; if your plan excludes weight-loss drugs entirely (many do), neither label helps and the broader coverage guide walks through what’s left. Honest caveat either way: switching labels fixes the eligibility question, not a plan that refuses the whole category.

If you do have type 2 diabetes and still got denied, that’s the denial worth appealing — your prescriber’s office files these routinely, and documentation of the diagnosis plus prior medications usually carries it.

Does Medicare cover Mounjaro?

For type 2 diabetes, yes — through Part D prescription plans. Formulary placement and prior-authorization rules vary by plan, and Part D’s annual out-of-pocket cap (around $2,000 ⚠ verify current figure) has made a real difference for people on expensive brand-name diabetes drugs.

For weight loss, no — Medicare is barred from covering weight-loss medications (⚠ policy in flux; proposals to change this surface regularly). And note the stacking problem: Lilly’s savings card excludes government insurance, so Medicare enrollees can’t use it to lower their copays.

How to pay less for Mounjaro

• Use the savings card — if you qualify. Commercial insurance that covers Mounjaro for type 2 diabetes gets copays as low as $25 a month. Read the fine print: government insurance is excluded, annual savings caps apply, and terms change without much notice (⚠ verify current card terms).
• Appeal a wrongful denial. If you have T2D and got denied anyway, that’s a paperwork fight worth having — and one prescribers win regularly.
• If the prescription is for weight, switch the label, not the drug. Ask about Zepbound. It’s the same medication with a weight-management approval, and it’s the only version a weight-loss PA can approve.
• Don’t wait for a generic. Tirzepatide is under patent; no FDA-approved generic exists, and anything marketed as “generic Mounjaro” isn’t one.
• Know the compounded landscape — carefully. Compounded tirzepatide occupies a legal grey zone since the FDA declared the shortage over. Some telehealth outfits still sell it; quality and legality vary. We cover that terrain informationally in the tirzepatide guide — it’s a landscape to understand, not a recommendation.
• Spend pre-tax dollars. FSA and HSA funds apply to prescription costs, which effectively discounts whatever you do end up paying.

Side effects, not price, are the other reason people bail early — if that’s the fork you’re at, the side-effects guide covers what fades and what doesn’t.